Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Open Access | 10.1172/JCI185067

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

Callum Beach, David MacLean, Dominika Majorova, Stavros Melemenidis, Dhanya K. Nambiar, Ryan K. Kim, Gabriel N. Valbuena, Silvia Guglietta, Carsten Krieg, Mahnaz Darvish-Damavandi, Tatsuya Suwa, Alistair Easton, Lily V.S. Hillson, Ashley K. McCulloch, Ross K. McMahon, Kathryn Pennel, Joanne Edwards, Sean M. O’Cathail, Campbell S. Roxburgh, Enric Domingo, Eui Jung Moon, Dadi Jiang, Yanyan Jiang, Qingyang Zhang, Albert C. Koong, Trent M. Woodruff, Edward E. Graves, Tim Maughan, Simon J.A. Buczacki, Manuel Stucki, Quynh-Thu Le, Simon J. Leedham, Amato J. Giaccia, and Monica M. Olcina

Find articles by Beach, C. in: PubMed | Google Scholar

Find articles by MacLean, D. in: PubMed | Google Scholar |

Find articles by Majorova, D. in: PubMed | Google Scholar

Find articles by Melemenidis, S. in: PubMed | Google Scholar |

Find articles by Nambiar, D. in: PubMed | Google Scholar |

Find articles by Kim, R. in: PubMed | Google Scholar |

Find articles by Valbuena, G. in: PubMed | Google Scholar |

Find articles by Guglietta, S. in: PubMed | Google Scholar |

Find articles by Krieg, C. in: PubMed | Google Scholar |

Find articles by Darvish-Damavandi, M. in: PubMed | Google Scholar |

Find articles by Suwa, T. in: PubMed | Google Scholar |

Find articles by Easton, A. in: PubMed | Google Scholar |

Find articles by Hillson, L. in: PubMed | Google Scholar |

Find articles by McCulloch, A. in: PubMed | Google Scholar |

Find articles by McMahon, R. in: PubMed | Google Scholar

Find articles by Pennel, K. in: PubMed | Google Scholar |

Find articles by Edwards, J. in: PubMed | Google Scholar |

Find articles by O’Cathail, S. in: PubMed | Google Scholar

Find articles by Roxburgh, C. in: PubMed | Google Scholar

Find articles by Domingo, E. in: PubMed | Google Scholar |

Find articles by Moon, E. in: PubMed | Google Scholar |

Find articles by Jiang, D. in: PubMed | Google Scholar |

Find articles by Jiang, Y. in: PubMed | Google Scholar |

Find articles by Zhang, Q. in: PubMed | Google Scholar

Find articles by Koong, A. in: PubMed | Google Scholar

Find articles by Woodruff, T. in: PubMed | Google Scholar |

Find articles by Graves, E. in: PubMed | Google Scholar |

Find articles by Maughan, T. in: PubMed | Google Scholar |

Find articles by Buczacki, S. in: PubMed | Google Scholar

Find articles by Stucki, M. in: PubMed | Google Scholar

Find articles by Le, Q. in: PubMed | Google Scholar

Find articles by Leedham, S. in: PubMed | Google Scholar

Find articles by Giaccia, A. in: PubMed | Google Scholar

Find articles by Olcina, M. in: PubMed | Google Scholar |

Published August 15, 2024 - More info

Published in Volume 134, Issue 16 on August 15, 2024
J Clin Invest. 2024;134(16):e185067. https://doi.org/10.1172/JCI185067.
© 2024 Beach et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published August 15, 2024 - Version history
View PDF

Related article:

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1
Callum Beach, … , Amato J. Giaccia, Monica M. Olcina
Callum Beach, … , Amato J. Giaccia, Monica M. Olcina
Research Article Cell biology Oncology

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

  • Text
  • PDF
Abstract

An immunosuppressive microenvironment causes poor tumor T cell infiltration and is associated with reduced patient overall survival in colorectal cancer. How to improve treatment responses in these tumors is still a challenge. Using an integrated screening approach to identify cancer-specific vulnerabilities, we identified complement receptor C5aR1 as a druggable target, which when inhibited improved radiotherapy, even in tumors displaying immunosuppressive features and poor CD8+ T cell infiltration. While C5aR1 is well-known for its role in the immune compartment, we found that C5aR1 is also robustly expressed on malignant epithelial cells, highlighting potential tumor cell–specific functions. C5aR1 targeting resulted in increased NF-κB–dependent apoptosis specifically in tumors and not normal tissues, indicating that, in malignant cells, C5aR1 primarily regulated cell fate. Collectively, these data revealed that increased complement gene expression is part of the stress response mounted by irradiated tumors and that targeting C5aR1 could improve radiotherapy, even in tumors displaying immunosuppressive features.

Authors

Callum Beach, David MacLean, Dominika Majorova, Stavros Melemenidis, Dhanya K. Nambiar, Ryan K. Kim, Gabriel N. Valbuena, Silvia Guglietta, Carsten Krieg, Mahnaz Darvish-Damavandi, Tatsuya Suwa, Alistair Easton, Lily V.S. Hillson, Ashley K. McCulloch, Ross K. McMahon, Kathryn Pennel, Joanne Edwards, Sean M. O’Cathail, Campbell S. Roxburgh, Enric Domingo, Eui Jung Moon, Dadi Jiang, Yanyan Jiang, Qingyang Zhang, Albert C. Koong, Trent M. Woodruff, Edward E. Graves, Tim Maughan, Simon J.A. Buczacki, Manuel Stucki, Quynh-Thu Le, Simon J. Leedham, Amato J. Giaccia, Monica M. Olcina

×

Original citation: J Clin Invest. 2023;133(23):e168277. https://doi.org/10.1172/JCI168277

Citation for this corrigendum: J Clin Invest. 2024;134(16):e185067. https://doi.org/10.1172/JCI185067

During the preparation of this manuscript, the dose for PMX205 used for in vitro experiments was stated incorrectly in the legend for Figure 3A and in the Methods. In addition, the statement in Methods regarding staining for C5aR1 using the Leica BOND autostainer was incorrect. The correct sentences are below. The HTML and PDF files have been updated.

(A) HCT116 cells were treated with either vehicle or PMX205 (10 μg/mL) for 48 hours.

PMX205 treatment. For all in vitro experiments, cells were treated with 10 μg/mL PMX205 (Tocris, 5196) dissolved in 20% ethanol/water.

Proliferation assays. HCT116 or MC38 cells were seeded at the indicated concentration. Cells were treated with 10 μg/mL PMX205 (or RNAse-Free water as vehicle). On day 2, cells were counted using a hemocytometer and trypan blue in a 1:1 ratio. On day 3, 10 μg/mL PMX205 (or water) was added to the dishes.

C5aR1 (Abcam, catalog ab59390) was stained for chromogenically on the Leica BOND autostainer on a serial section.

The authors regret the errors.

Footnotes

See the related article at Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.

Version history
  • Version 1 (August 15, 2024): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts